Background and aim: Studies on weaning strategies have yielded conflicting results regarding the superiority of different methods. The aim of this RCT was to compare the efficacy of gradual pressure support (PS) reduction without an initial spontaneous breathing trial (SBT) with PSsupported SBT. Methods: Patients mechanically ventilated for >24 h were randomized to weaning by gradual reduction of PS without an initial SBT versus once daily SBT (PS 7 cm H 2 O). The primary outcomes were the rates of successful weaning trial and time to successful extubation. The secondary outcomes were the ICU and hospital length of stay, hospital mortality and the occurrence of ventilator-associated pneumonia (VAP). Results: Of the 120 patients (61 males, median age 35 years), 58 were assigned to PS and 62 to the SBT group. The median (IQR) duration of ventilation prior to weaning was 80.2 (50.5---175.6) h. The baseline characteristics were similar in the two groups except the PaO 2 /FiO 2 ratio, which was significantly higher in SBT group. The rates of successful weaning trial (89.7% versus 69.4%) were significantly higher in the PS group. The median duration of weaning (66 h versus 81.5 h, P = 0.05) and the median duration of ICU stay (8 days versus 9.4 days, P = 0.027) were lower in the PS group. There was no difference in hospital stay, mortality rates or occurrence of VAP in the two arms. On multivariate analysis, the duration of ventilation prior to weaning, baseline SOFA score and the weaning method were predictors of successful extubation. Conclusions: Gradual reduction of PS without an initial SBT was found to be associated with better outcomes compared to once daily PS-supported SBT. 
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Introduction
Weaning from mechanical ventilation allows patients to resume their spontaneous breathing. 1 Almost 40---50% of the total duration of mechanical ventilation is spent on the weaning process. 2 Delayed weaning not only exposes the patient to increased cost of intensive care but also increased risk of complications. 3 ---5 Hospital mortality increases with prolonged mechanical ventilation, in part because of complications like ventilator-associated pneumonia (VAP) and airway trauma. 5 On the other hand, premature weaning is associated with difficulty in reestablishing artificial airway, compromised gas exchange, high incidence of VAP and increased mortality. 6 The major factor in successful weaning is resolution of the precipitating illness. Other factors include the comorbid illnesses, cause of acute respiratory failure (ARF), protocol and the method of weaning. Among these, the method of weaning is an important variable because of the potential to intervene. The major weaning studies have been conducted using spontaneous T-piece trials and pressure support (PS) ventilation. 7, 8 In these studies, readiness to wean has been assessed by an initial 2 h T-piece trial; patients who tolerate this trial are extubated whereas those failing this trial are randomized to different weaning methods. The reintubation rates of the initial spontaneous breathing trials (SBTs) have ranged from 10 to 20%. 7---11 Since the inception of our respiratory intensive care unit (RICU), it has been the practice to wean patients by gradual PS reduction without employing an initial SBT. No study has compared the efficacy and safety of a weaning method without an initial SBT as the initial strategy. We hypothesized that weaning would be more physiological once PS is gradually decreased, and could potentially result in better outcomes than initial SBTs. The aim of this randomized controlled trial (RCT) was to examine the efficacy and safety of two different weaning methods viz. gradual reduction of PS without an initial SBT versus SBTs using low-level PS.
Material and methods
The study was conducted between January 2008 and June 2009 in the RICU of this institute, and was approved by the Ethics Committee (PGIMER Ethics Committee; VS/1353). An informed consent was taken from all the patients or their relatives. All data in the RICU were entered prospectively into a computer program specifically designed for this purpose as previously described.
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Inclusion criteria
Patients with ARF requiring mechanical ventilation for more than 24 h were included. The severity of the underlying illness and the quantum of the organ dysfunction/failure appearing after RICU admission were scored using SOFA scores. 13 New-onset organ dysfunction/failure was computed using SOFA score, by subtracting the SOFA score at admission from the maximum SOFA during the ICU stay. 14 Figure 1 Algorithm depicting the entire protocol, from randomization of the patient to implementation of the two methods of weaning.
All patients received volume-targeted assist control mode
ventilation (ACMV) for their initial management. Patients who required ventilatory support for longer periods underwent tracheostomy as indicated. Weaning was attempted when there was significant improvement in the underlying cause. ACMV was stopped and patients were allowed to breathe spontaneously for 5 min at continuous positive airway pressure (CPAP) of 5 cm H 2 O, with the FiO 2 set at the same level. Patients with respiratory rate ≤35 min −1 , tidal volume ≥5 mL/kg and a rapid shallow breathing index (RSBI) <100 breaths per min/L were eligible for randomization into the trial. RSBI was obtained as the ratio of frequency to tidal volume during the first minute of the trial. In addition, most of the following clinical and laboratory criteria had to be satisfied: body temperature <38
• C, ability to respond to simple commands, minimal tracheobronchial secretions, hemoglobin ≥7 gm/dL, systolic blood pressure (SBP) ≥100 mm Hg without vasopressor support, PaO 2 ≥60 mm Hg (or pulse oximetric saturation ≥92%) at FiO 2 of ≤0.4, PaCO 2 ≤45 mm Hg (≤55 mm Hg in COPD patients) and PaO 2 /FiO 2 ≥250. Finally, the ICU physician had to agree that the patient was stable and ready to be weaned from the ventilator.
Exclusion criteria
Pregnancy, age under 12 years, post-operative patients, failure to give informed consent and death prior to weaning from mechanical ventilation were the exclusion criteria.
Randomization
Patients meeting the inclusion criteria were randomized to weaning by either gradual reduction of PS without an initial SBT (PS group) or SBT with a fixed PS of 7 cm H 2 O (SBT group). The randomization sequence was computer generated and the assignments (placed in sealed opaque envelopes) were made prior to weaning. Blinding of allocation was not possible.
Pressure support group
PS was instituted (equivalent to the plateau pressure of the patient during ACMV) along with CPAP of 5 cm of H 2 O. Thereafter PS was adjusted until the respiratory rate was ≤30 breaths/min. The PS was reduced by 2 cm H 2 O every 6 h or earlier as clinically indicated. Patients were considered fit for extubation if they tolerated PS of 7 cm H 2 O for at least 1 h. If there were signs of intolerance, PS was increased to the preceding level and reassessment for weaning was performed after a period of 6 h. If signs of intolerance persisted despite an increase in PS, ACMV was reinstituted.
Spontaneous breathing trial group
SBT was administered using a PS of 7 cm H 2 O, and patients were monitored continuously for the first 5 min and then every 15 min of the trial. Patients who tolerated the SBT for 1 h were considered fit for extubation. If there were any signs of intolerance, ACMV was reinstituted. Patients failing the first SBT were reassessed after 24 h for the next SBT. The final decision to extubate was left to the intensivist's clinical judgment.
Intolerance to the weaning trial
Was defined as increase in respiratory frequency by >30% from baseline, heart rate >140 beats/min or a rise 
Post-extubation
All patients were monitored for 48 h following extubation. Supplemental oxygen or noninvasive ventilation (NIV) was used as clinically indicated. Patients were followed up till the hospital discharge. The entire protocol is schematically shown in Fig. 1 .
Outcomes
The primary outcomes were the rates of weaning failure and the total duration of weaning. The secondary outcomes were the ICU and hospital length of stay, hospital mortality and the occurrence of VAP. Successful weaning trial was defined as lack of reinstitution of full ventilatory support at any time during the weaning process. Extubation success was considered if there was no requirement of intubation within 48 h of extubation. In tracheostomized patients, withdrawal from ventilatory support and its reinstitution were considered equivalents to extubation and reintubation, respectively.
Statistical analysis
Data are presented as mean (SD), median (IQR) or number with percentages. All categorical variables were analysed using the chi-square test. Differences between continuous variables were performed using the Student's t test or Mann Whitney U test. A multivariable logistic regression analysis was performed to study the factors predicting successful extubation.
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Results
During the study period, 184 patients were mechanically ventilated in the RICU. Thirty-two died prior to the onset of weaning, eight patients were ventilated for <24 h, and 20 patients did not provide written consent and were not included in the study (Fig. 2) . Sixty-four males and 60 females with a median (IQR) age of 35 (24---50) years were included in the trial. The mean (SD) SOFA score at admission was 5.4 (3.8). 
Primary outcomes
The numbers of patients with successful weaning trial ( Table 2) were significantly higher in the PS group compared to the SBT group (PS group ---52/58 versus SBT group ---43/62). All these patients were extubated; however, five patients in each group who underwent successful weaning trial (5/52 versus 5/43, P = 0.75) required reintubation. The median duration of weaning was 66 h in the PS group versus 73.5 h in the SBT group with trend towards quicker weaning in the PS group. As it is difficult to judge success or failure rates in tracheostomized patients, which could be a major confounding factor, the analysis was repeated after excluding patients with tracheostomy. There was no difference in any of the primary outcomes in patients with and without tracheostomy ( Table 2) .
Secondary outcomes
The duration of stay in the RICU was significantly lower in the PS group. However, the duration of hospital stay was similar in the two groups (Table 2 ). There was no difference in the mortality rates, occurrence of VAP and the need for tracheostomy or post-extubation NIV in the two groups. However, the duration of RICU stay was significantly shorter in the SBT group; compared to the PS group ( Table 2) . The time to failure of a weaning trial was significantly shorter in the SBT group; however, there was no difference between the two groups after excluding patients with tracheostomy (Table 2) . Six and 19 patients in the PS and SBT group, respectively, failed the weaning trial and required prolonged attempts at weaning (Table 3) . Of the 25 patients in both the groups who failed the weaning trial, nine patients died prior to further attempts at weaning. Sixteen patients were eventually weaned, and prolonged weaning was encountered in 10 patients. Among those reintubated (n = 10), four patients died and the weaning process was prolonged in the remaining six. Three patients who were successfully weaned died during the hospital stay.
Logistic regression analysis was performed to ascertain the variables predicting successful extubation. In the multivariate model, after adjustment, the variables that predicted outcome were duration of ventilation prior to weaning, baseline SOFA score and the weaning strategy (Table 4) . Once patients with tracheostomy were excluded, the variables that predicted outcome were duration of ventilation prior to weaning and the weaning strategy (Table 4) .
Discussion
The results of the study suggest that weaning by gradual reduction of PS without an initial SBT was associated with better outcomes (in terms of higher weaning trial successes, shorter ICU stay and trend towards quicker time to extubation) than weaning by PS-supported SBTs. This study was conducted in the RICU of a tertiary referral institute manned by intensivists and nursing staff well trained in ventilatory strategies. Our patient profile included medical patients with respiratory failure of various etiologies. Randomization ensured comparability between the two groups. The only significant difference was a higher PaO 2 /FiO 2 ratio in the SBT group, which is unlikely to affect the results as the other parameters were well matched. We also ensured strict adherence to the protocol including the criteria used for altering the level of PS or extubation.
In the SBT arm, trials were conducted every 24 h as once daily SBTs with a rest period of 24 h are associated with best outcomes. 7, 8 Two trials have shown that once daily SBT is associated with higher weaning success compared to multiple trials. 7, 8 Esteban et al. showed that 30 min SBTs are as effective as 120 min trials in achieving successful extubation with similar reintubation and mortality rates. 11 Also, longer duration of SBTs may delay the recovery of muscle function as reflected by the longer ICU stays in the 120 min group in their study. 11 Most patients who fail an initial SBT do so in the first 20 min with the success rate being similar in 30 and 120 min trials. 9, 11 Hence, the duration of the SBT was limited to 1 h in our study to further reduce the monitoring time and the workload on the RICU staff. We used PS of 7 cm H 2 O for SBT as it was shown that the number of successful extubation was 10% higher in SBT performed with PS of 8 cm H 2 O than with T-piece with similar reintubation rates. 9 Brochard Table 4 Predictors of successful extubation----multivariate analysis in patients with and without tracheostomy. 16 Another advantage of SBT with a specified PS over a T-piece trial is that it does not require disconnection from the ventilator, and ensures safety in a resource constrained ICU.
Two large studies have investigated gradual withdrawal of ventilatory support. 7, 8 However, these studies included patients by an initial 2 h SBT with those failing SBT randomized to PS reduction, synchronized intermittent mandatory ventilation (SIMV) or SBTs. These trials established that SIMV was associated with longer duration of weaning than the other two methods. Studies using initial T-piece trials have produced failure rates ranging from 12 to 32%.
7---11 Our study is different from these studies in that we directly randomized patients to gradual PS reduction without initial SBT, and the results suggest that this strategy is as effective as PSsupported SBT. However, a larger RCT is required to confirm the results of our study. The PS group in our study had lesser duration of weaning and shorter ICU stay consistent with earlier results. 7 However, one study reported that the duration of weaning was significantly shorter with T-piece trials than PS. 8 One possible reason could be the restrained manner in which PS was reduced in this study wherein a respiratory rate cutoff of <25 breaths/min was required for reduction of PS whereas intolerance to T-piece trial was considered at 35 breaths/min. 8 Also, prior to extubation, the patients had to tolerate a PS of 5 cm of H 2 O for 2 h. This may have led to slower reduction of PS and hence a longer duration of weaning. Further, this study did not consider the failure of T-piece trials requiring reinstitution of ventilation in their outcomes.
The failure rate of SBT was 30% in our study similar to previous reports of 26---42%. 4, 7, 8, 11 The reintubation rate of 8% is consistent with earlier reintubation rates of 4---19%. 4,7---9,17 The median time to failure of the first weaning trial was 43 and 25 min in the PS and SBT arms, respectively. The time to failure of the weaning trial is shorter in the SBT group because PS effectively assists each spontaneous breath and hence reduces the respiratory workload imposed on the respiratory muscles. 18---20 The short duration of trial failure re-emphasizes that 60 min SBTs are as effective as the 120 min trials. The PS group also had shorter ICU stay compared to the SBT group consonant to quicker weaning. The occurrence of VAP in reintubated patients was 70% in our study compared to 17% in those without reintubation, which is similar to previous observation. 17 In the multivariate model, the baseline SOFA score, the duration of ventilation prior to weaning and the weaning method significantly influenced successful weaning trials. Vallverdu et al. in a study on factors affecting the weaning outcome in diverse cause of mechanically ventilated patients also found duration of ventilation as a significant factor associated with weaning success. 10 Kollef et al. found that baseline APACHE II score was one of the factors that predicted successful weaning. 5 Our study has number of limitations. We used an unconventional method to assess the readiness to wean, i.e. CPAP of 5 cm H 2 O. As the study compares the standard SBT method to gradual PS reduction, there was a need for an initial short trial of CPAP to objectively select patients for randomization into the trial. The study has a small sample size and includes diverse causes of respiratory failure. However, our study population was more homogenous than previous studies as we included only medical patients. The absence of blinding is a potential for bias in the study but blinding was not possible as this was an intervention study in critically ill patients that required close monitoring following intervention. Another limitation of the study is the inclusion of patients with tracheostomy (number similar in both arms), and the definitions for extubation and reintubation in this group of patients. Similarly, the use of NIV following extubation is another source of bias although its use was at the discretion of the attending physician and the number in which it was applied was small. The strength of the study is the evaluation of a hitherto uninvestigated method of weaning.
In conclusion, weaning by gradual reduction of PS without an initial SBT was associated with higher success rates, quicker weaning, and a shorter ICU stay versus once daily PS-supported SBTs. However, RCTs with a larger sample size are required to confirm the results of our findings.
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